Filing Details
- Accession Number:
- 0001455244-12-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-07 15:59:31
- Reporting Period:
- 2012-08-03
- Filing Date:
- 2012-08-07
- Accepted Time:
- 2012-08-07 15:59:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 827809 | Qlt Inc | QLTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554591 | Sukhi Jagpal | C/O Qlt Inc. 887 Great Northern Way, Suite 101 Vancouver A1 V5T 4T5 | Interim Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-03 | 20,000 | $3.74 | 21,200 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-03 | 15,000 | $2.44 | 36,200 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-03 | 12,000 | $6.28 | 48,200 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-03 | 20,000 | $7.21 | 68,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-03 | 67,000 | $8.19 | 1,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2012-08-03 | 20,000 | $0.00 | 20,000 | $3.74 |
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2012-08-03 | 15,000 | $0.00 | 15,000 | $2.44 |
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2012-08-03 | 12,000 | $0.00 | 12,000 | $6.28 |
| Common Stock | Employee Stock Options (right to buy) | Disposition | 2012-08-03 | 20,000 | $0.00 | 20,000 | $7.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-05-17 | No | 4 | M | Direct | |
| 0 | 2014-05-04 | No | 4 | M | Direct | |
| 0 | 2015-05-21 | No | 4 | M | Direct | |
| 0 | 2016-05-25 | No | 4 | M | Direct |
Footnotes
- Price reflects the conversion of Canadian dollars to US dollars based on the noon exchange rate published by the Bank of Canada on the date of the reportable event.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from US $8.12 to US $8.39 inclusive. The reporting person undertakes to provide to any security holder of QLT, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The option vested in 36 equal monthly installments measured from May 17, 2008 and became fully exercisable on May 17, 2011.
- The option vested in 36 equal monthly installments measured from May 4, 2009 and became fully exercisable on May 4, 2012.
- The option originally providing for vesting in 36 equal monthly installments measured from May 21, 2010. However, in connection with a change in control of the Company (as defined in the option agreement), the unvested shares under such option were accelerated and became fully exercisable on June 4, 2012.
- The option originally provided for vesting in 36 equal monthly installments measured from May 25, 2011. However, in connection with a change in control of the Company (as defined in the option agreement), the unvested shares under such option were accelerated and became fully exercisable on June 4, 2012.
Billionaire Hedge Funds
